The antimycobacterial activity of new 18 7-chloroquinoline derivatives, obtained from 4,7-dichloroquinoline, was evaluated against 15 Mycobacterium spp among standardized and clinical isolates using the MTT susceptibility test to obtain minimum inhibitory concentration values (MIC, μg/mL). The results suggested that 7-chloroquinoline compounds are useful leads for new anti-TB drug development. The most active compounds exhibited moderate activity with 16 μg/mL MIC values for all tested microorganisms.
新型18个
7-氯喹啉衍
生物的抗分枝杆菌活性,采用M
TT敏感性测试对15种分枝杆菌(包括标准株和临床分离株)进行了评估,以获得最小抑菌浓度值(MIC,μg/mL)。结果表明,
7-氯喹啉化合物是新型抗结核药物开发的有用先导化合物。活性最强的化合物对所有测试微
生物的MIC值为16 μg/mL,表现出中等活性。